ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2016

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.

A Patnaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.